Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vaughan, Michelle
ICON9, NCT03278717 / 2017-000161-75: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients	Recruiting	3	330	Europe, Canada, RoW	Olaparib, Cediranib	University College, London, Cancer Research UK, AstraZeneca UK Limited	Ovarian Cancer	12/23	12/23